Navigation Links
Abaxis To Report First Quarter Fiscal Year 2013 Financial Results Thursday, July 26, 2012
Date:7/17/2012

UNION CITY, Calif., July 17, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the first quarter of fiscal year 2013, ended June 30, 2012. The call will be at 4:15 p.m. ET on Thursday, July 26, 2012.  The Company will report financial results for the first quarter of fiscal 2013 after the market closes on Thursday, July 26, 2012.

Participants can dial (877) 317-6789 or (412) 317-6789 to access the conference call, or can listen via a live Internet web cast, which is available in the Investor Relations section of the Company's website at www.abaxis.com. A replay of the call is available by visiting www.abaxis.com for the next 30 days or by calling (877) 344-7529 or (412) 317-0088, confirmation code 10016194, through July 31, 2012.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.Contact:

Clint Severson

Lytham Partners, LLC Chief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum Abaxis, Inc.

602-889-9700 510-675-6500
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Abaxis Enters Into Definitive Agreement To Deliver 300 Piccolo Xpress Instruments For A Four-Year Drug Clinical Trial
2. Abaxis, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
3. U.S. End-User Dental Materials Survey Report 2012
4. China Genetic Engineering Drug Industry Report, 2011-2012
5. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
6. Regeneron to Report Second Quarter 2012 Financial and Operating Results and Host Conference Call and Webcast on July 25, 2012
7. China Pharmaceuticals and Healthcare Report Q3 2012
8. Questcor to Report Second Quarter Results on July 24, 2012
9. CareFusion To Report Fourth Quarter And Fiscal 2012 Results On Aug. 9
10. India Pharmaceuticals and Healthcare Report Q3 2012
11. Par Pharmaceutical Companies to Report Second Quarter 2012 Results on August 2, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... SAN ANTONIO , Sept. 6, 2017  Robert ... as a Pinnacle Professional Member in recognition of his ... Dr. Szewc serves as a Nephrologist at the practice ... services, emergency medicine, kidney care and hypertension solutions. He ... over 20 years of career experience, as well as ...
(Date:9/6/2017)...   PDI , a leader in infection prevention ... educational session focused on the role of chlorhexidine gluconate ... the 2017 Annual Scientific Meeting of the Association for ... the Phoenix Convention Center in ... will also feature PDI,s Prevantics® Device Swab ...
(Date:9/6/2017)... INDIANAPOLIS , Sept. 6, 2017 Eli ... today it will present new data for galcanezumab and ... Congress of the International Headache Society (IHC) taking place ... Lilly will highlight new, long-term data from ... two doses of galcanezumab (120 mg and 240 mg) ...
Breaking Medicine Technology:
(Date:9/19/2017)... ... September 19, 2017 , ... The ISO 9001 standard ... businesses and organizations become more efficient and improve customer satisfaction. ISO 9001:2015 was released ... own QMS, with a deadline of September 2018. , As described in ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... developed by a neurosurgeon, has received a big bump in sales after ... Booster is currently available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, RevNutrition.com ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... has agreed to serve as strategic adviser to the animal healthcare division ... of the Bridge Animal Referral Center (BARC) in Edmonds, Washington, which specializes ...
(Date:9/19/2017)... ... September 19, 2017 , ... First Choice Emergency ... named Dr. Howard Ng, as the new Medical Director of its Pflugerville- FM 685 ... facility Medical Director of our Pflugerville- FM 685 location,” said Dr. Stephen Van Roekel, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Ron Norman, CEO of Team ... importance of making a distinct rather than generic impression in the job market if ... through a stack of resumes knows that the first impression they give off is ...
Breaking Medicine News(10 mins):